These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 11845948)

  • 1. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients.
    Jacyk WK; Mpofu P
    Cutis; 2001 Oct; 68(4 Suppl):48-54. PubMed ID: 11845948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients.
    Zhu XJ; Tu P; Zhen J; Duan YQ
    Cutis; 2001 Oct; 68(4 Suppl):55-9. PubMed ID: 11845949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting.
    Baker M; Tuley M; Busdiecker FL; Herndon JH; Slayton RM
    Cutis; 2001 Oct; 68(4 Suppl):41-7. PubMed ID: 11845947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
    Lucky A; Jorizzo JL; Rodriguez D; Jones TM; Stewart DM; Tschen EH; Kanof NB; Miller BH; Wilson DC; Loven KH
    Cutis; 2001 Oct; 68(4 Suppl):34-40. PubMed ID: 11845946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D; Arsonnaud S; Soto P
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapalene in the treatment of African patients.
    Jacyk WK
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():37-42. PubMed ID: 11843232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
    Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
    Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
    Ioannides D; Rigopoulos D; Katsambas A
    Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
    J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
    Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
    Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
    Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
    Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study.
    Kawashima M; Harada S; Loesche C; Miyachi Y
    J Dermatol Sci; 2008 Mar; 49(3):241-8. PubMed ID: 18063345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
    Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarized light photography and videomicroscopy greatly enhance the capability of estimating the therapeuic response to a topical retinoid (adapalene) in acne vulgaris.
    Rizova E; Pagnoni PA; Stoudemayer T; Poncet M; Kligman AM
    Cutis; 2001 Oct; 68(4 Suppl):25-33. PubMed ID: 11845945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Egan N; Loesche MC; Baker MM
    Cutis; 2001 Oct; 68(4 Suppl):20-4. PubMed ID: 11845944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
    Poulin Y; Sanchez NP; Bucko A; Fowler J; Jarratt M; Kempers S; Kerrouche N; Dhuin JC; Kunynetz R
    Br J Dermatol; 2011 Jun; 164(6):1376-82. PubMed ID: 21457209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
    Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
    J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.